Verity Asset Management’s Nu Skin NUS Stock Holding History

Verity Asset Management’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$444K	Buy	9,270 +713	+8%	+$35.3K	0.28%	111
2021 Q4	$434K	Buy	+8,557	New	+$380K	0.26%	115

Other funds holding NUS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Verity Asset Management's NUS Position: Q1 2022 in Review

Verity Asset Management increased its Nu Skin (NUS) stake by 8.3% in Q1 2022, buying an estimated $35.3K and bringing the position to 9,270 shares worth $444K. The position accounts for 0.28% of the portfolio, ranked #111.

Verity Asset Management first reported a position in NUS in Q4 2021 and has held it in 2 quarters since. 238 funds tracked by Wall St. Rank hold NUS as of Q1 2022.

Verity Asset Management held 9,270 shares of Nu Skin worth $444K as of Q1 2022.
Verity Asset Management bought 713 Nu Skin shares in Q1 2022, an estimated $35.3K.
Nu Skin made up 0.28% of Verity Asset Management's portfolio in Q1 2022, its #111 holding.
Verity Asset Management first reported a position in Nu Skin in Q4 2021 and has held it in 2 quarters since.
238 funds tracked by Wall St. Rank held Nu Skin as of Q1 2022.

Based on Verity Asset Management's 13F filing for Q1 2022, filed 12 May 2022.